Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
18 hedge funds and large institutions have $1.19M invested in Bio-Path Holdings Inc in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 0 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
40% more capital invested
Capital invested by funds: $847K → $1.19M (+$338K)
29% more funds holding
Funds holding: 14 → 18 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$168K |
| 2 |
VF
Virtu Financial
New York
|
+$125K |
| 3 |
Goldman Sachs
New York
|
+$63K |
| 4 |
Renaissance Technologies
New York
|
+$61.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$50.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$6.68K |
| 2 |
Morgan Stanley
New York
|
-$600 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $339K | +$168K | +2,241 | +86% |
|
|
2
Renaissance Technologies
New York
| $272K | +$61.8K | +824 | +27% |
|
3
BlackRock
New York
| $210K | – | – | – |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $119K | +$50.8K | +677 | +66% |
|
|
VF
5
Virtu Financial
New York
| $116K | +$125K | +1,662 | New |
|
|
6
Goldman Sachs
New York
| $59K | +$63K | +840 | New |
|
|
WJA
7
Willis Johnson & Associates
Houston,
Texas
| $40K | +$42.7K | +569 | New |
|
8
Bank of America
Charlotte,
North Carolina
| $8K | +$9.01K | +120 | +12,000% |
|
|
9
Morgan Stanley
New York
| $7K | -$600 | -8 | -8% |
|
|
HI
10
Human Investing
Lake Oswego,
Oregon
| $7K | – | – | – |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $6K | +$6.3K | +84 | New |
|
|
12
UBS Group
Zurich,
Switzerland
| $2K | -$6.68K | -89 | -74% |
|
13
Wells Fargo
San Francisco,
California
| – | +$75 | +1 | +100% |
|
BPTH Hedge Fund Activity: Q4 2020 in Review
18 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q4 2020, worth a combined $1.19M — up 40% from $847K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BPTH positions and 0 closed out — a net gain of 4 holders — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $168K. The largest seller was UBS Group, cutting an estimated $6.68K.
- 18 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q4 2020, up from 14 in Q3 2020.
- Funds reported $1.19M of Bio-Path Holdings Inc stock for Q4 2020, up 40% quarter-over-quarter.
- 4 funds opened new Bio-Path Holdings Inc positions in Q4 2020 and 0 closed out, a net change of +4 holders.
- The largest Bio-Path Holdings Inc buyer in Q4 2020 was Vanguard Group, an estimated $168K added.
- The largest Bio-Path Holdings Inc seller in Q4 2020 was UBS Group, an estimated $6.68K sold.
Based on aggregated 13F filings for Q4 2020.